ALDH1A3 and breast carcinoma: We next performed western blotting, gene expression, and microscopy analyses to investigate for potential molecular changes induced by ALDH1A3 in the breast cancer cells that would result in the intermediate/partial EMT phenotype we observed in Fig. 2 (Fig. 3).